Abstract
The effects of apomorphine, a D1-D2 dopamine receptor agonist, on the extracellular concentration of glutamate were investigated in the medial prefrontal cortex of young, middle-aged and aged rats. In vivo intracerebral perfusions were undertaken in the conscious rat using a concentric push-pull cannula system. Glutamate concentration in the samples were determined by HPLC with fluorometric detection. Apomorphine produced an increase in extracellular concentration of glutamate in medial prefrontal cortex of young rats (178% of baseline) only at 10 microM, but not at 5 and 20 microM. This increase in glutamate concentration induced by apomorphine was significantly attenuated by blockade of D1-D2 dopamine receptors with haloperidol. Apomorphine, at 10 microM, failed to induce an increase in extracellular concentration of glutamate in the prefrontal cortex of middle-aged and aged rats. However, at 20 microM, apomorphine induced an increase in glutamate concentration in the prefrontal cortex of middle-aged rats, but not in aged rats. These data indicate that an interaction between dopamine and glutamate exists in the medial prefrontal cortex and that this interaction deteriorates with age.
References
Nov 1, 1992·Neurobiology of Aging·M CoboF Mora
May 22, 1992·Brain Research·J M de BrabanderM G Feenstra
Jan 1, 1991·Neuroscience·S RétauxJ Penit-Soria
Dec 8, 1989·The Journal of Comparative Neurology·I DoriJ G Parnavelas
Nov 1, 1989·Neurobiology of Aging·R DawsonM J Meldrum
Feb 1, 1986·Brain Research Bulletin·A M ThierryJ Glowinski
Jan 13, 1987·Brain Research·E J MufsonD G Stein
Feb 23, 1988·Brain Research·P SéguélaL Descarries
Sep 1, 1987·Neuroscience·C G Van EdenH B Uylings
Jan 1, 1985·Annals of the New York Academy of Sciences·D K Ingram
Nov 1, 1984·The Journal of Comparative Neurology·O P Ottersen, J Storm-Mathisen
Jul 1, 1980·Experimental Neurology·C J Cupp, E Uemura
Jul 1, 1980·Experimental Neurology·E Uemura
Jun 1, 1994·Trends in Neurosciences·G Di ChiaraS Consolo
Oct 3, 1994·Neuroreport·G SegoviaF Mora
Jan 1, 1994·Brain Research Bulletin·J Sánchez-PrietoF Mora
Jan 1, 1994·Neurobiology of Aging·A M PalmerC T Reiter
Feb 1, 1994·The European Journal of Neuroscience·I ExpositoF Mora
May 1, 1994·Neuroscience·P Saransaari, S S Oja
Mar 1, 1993·Neurobiology of Aging·M CoboF Mora
May 1, 1993·Canadian Journal of Physiology and Pharmacology·F Mora, A Porras
Oct 25, 1993·Neuroreport·K Wedzony, K Gołembiowska
Dec 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M T Taber, H C Fibiger
Jan 22, 1993·Brain Research·J M de BrabanderM G Feenstra
Mar 1, 1993·The American Journal of Psychiatry·D DeptulaN Pomara
Nov 1, 1995·The European Journal of Neuroscience·A Porras, F Mora
Jul 14, 1995·Mechanisms of Ageing and Development·P Saransaari, S S Oja
Oct 1, 1990·The European Journal of Neuroscience·C. VerneyB. Berger
Citations
Jun 24, 2004·Neurobiology of Aging·Sarah J WorksCara L Wellman
Feb 13, 2001·Mechanisms of Ageing and Development·G SegoviaF Mora
Jan 12, 1999·Mechanisms of Ageing and Development·P BariliF Amenta
May 16, 2002·Neurobiology of Aging·Julie A Markham, Janice M Juraska
Aug 5, 2010·Journal of the International Neuropsychological Society : JINS·Arnaud RoyDidier Le Gall
Apr 4, 2009·Journal of Neural Transmission·Gregorio SegoviaFrancisco Mora
Feb 7, 2012·Progress in Neurobiology·Thomas C Foster
Jun 16, 2009·Neurochemistry International·Chang-Hun Chae, Hyun-Tae Kim
Nov 27, 2007·Brain Research Reviews·Francisco MoraAlberto Del Arco
Feb 1, 2005·Brain Research Bulletin·Gregorio Segovia, Francisco Mora
Nov 9, 2004·Neuroscience Letters·Kerstin WirknerPeter Illes
Feb 22, 2012·Addiction Biology·Osnat M Ben-ShaharNick Woodward